Module

Definitions of HBV Treatment Failure and Resistance

Source: Clinical Strategies for Preventing and Managing Resistance to Anti-HBV Agents

Definitions of HBV Treatment Failure and Resistance

Faculty:
Jean-Michel Pawlotsky, MD, PhD

CME CREDIT INFORMATION

Release Date: 04/14/06

Expiration Date: 04/13/07

Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Review virologic treatment endpoints and define treatment efficacy and failure in the setting of HBV infection
Discuss HBV resistance variants
Discuss the use of anti-HBV drugs in clinical practice

Topics covered include:

Introduction
Treatment Effect vs Treatment Efficacy
Treatment Endpoints
Antiviral Treatment Failure
HBV Resistance
Clinical Trials With HBV Drugs
Clinical Practice With Approved Anti-HBV Drugs

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.